Skip to content

Strategies for Prescribing Analgesics Comparative Effectiveness Trial

CompletedNot applicableNCT01583985
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Chronic musculoskeletal pain conditions are among the most prevalent conditions in VA primary care. Over the past two decades, improved clinical attention to pain has been associated with exponentially greater use of long-term opioid therapy for chronic non-cancer pain, both within and outside the VA system. Despite this change in practice, the proper place of opioids in chronic pain management continues to be controversial because research has not demonstrated the long-term safety and effectiveness of opioids for chronic musculoskeletal pain. The Strategies for Prescribing Analgesics Comparative Effectiveness (SPACE) Trial will fill a critical gap in the evidence by comparing effectiveness and harms of two clinically relevant analgesic prescribing strategies-one that emphasizes early use of strong opioids and one that delays and minimizes opioid use-for Veterans with chronic back, hip, or knee pain. SPACE is designed to be highly relevant to clinical decision-making in VA primary care and to produce knowledge that will improve the lives of Veterans living with chronic pain.

Study details

Official title
Strategies for Prescribing Analgesics Comparative Effectiveness (SPACE) Trial
Interventions
  • Other: Opioid-intensive prescribing strategy
  • Other: Opioid-avoidant prescribing strategy
Sponsor
VA Office of Research and Development
Start date
2013-06-01
Primary completion
2017-01-31
Sex
All
Age range
from 18 Years
Results posted
Yes, on ClinicalTrials.gov
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Veterans with chronic back or lower extremity osteoarthritis pain with moderate-severe intensity and interference with function despite analgesic therapy. Exclusion Criteria: * schizophrenia, bipolar disorder, or other psychosis; * moderately severe cognitive impairment; * anticipated back, knee, or hip surgery within 12 months; * anticipated life expectancy of less than 12 months; * current chronic daily opioid therapy; * absolute contraindications to either prescribing strategy.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01583985